InvestorsHub Logo
Followers 9
Posts 336
Boards Moderated 0
Alias Born 07/18/2016

Re: McMagyar post# 136740

Monday, 01/08/2018 9:55:27 AM

Monday, January 08, 2018 9:55:27 AM

Post# of 460648
Well stated McMagyar. It’s the short term perspective versus the long term perspective and as a long term holder of shares, I believe Missling does have the shareholders best interests in mind. Would I prefer that the three trials were already up and running? Of course, but until some obvious red flag becomes apparent, I’m a retail investor who trusts the process of getting these drugs to market and have the patience and perspective for the higher payout. My biggest concern going into 2018, is protection against a hostile take over, as some here are willing to sell out on the cheap and I’m not convinced Anavex has the proper poison pill in place to prevent such an attack? With the possibility/probability that off-shored monies in this improved corporate advantaged tax environment for Mergers and Acquisitions comes home to roost, Anavex Life Sciences looks like a bigger target than ever.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News